4//SEC Filing
Lawrence John H III 4
Accession 0001209191-17-063265
CIK 0001269021other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 5:35 PM ET
Size
7.4 KB
Accession
0001209191-17-063265
Insider Transaction Report
Form 4
Lawrence John H III
SVP, Chief Medical Officer
Transactions
- Award
Common Stock
2017-11-30+5,000→ 5,000 total - Award
Stock Option (Right to Buy)
2017-11-30+125,000→ 125,000 totalExercise: $50.75Exp: 2027-11-29→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]Grant of Restricted Stock Units ("RSU") in consideration of services rendered. The RSU vests annually over three years commencing on March 1, 2019, subject to Reporting Person's Continuous Service as of each such date.
- [F2]The Option shall vest as follows: 25% of the shares shall vest one year from the Vesting Commencement Date of November 6, 2017, and the remaining shares shall vest ratably over the next 36 months.
Documents
Issuer
PORTOLA PHARMACEUTICALS INC
CIK 0001269021
Entity typeother
Related Parties
1- filerCIK 0001721090
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 5:35 PM ET
- Size
- 7.4 KB